• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

Administering Plasma Therapy Requires Pharmacist Collaboration With a Specialty Care Team

by MM360 Staff | May 27, 2025 | Myeloma News

Source: Pharmacy Times articles Pharmacists can make the process easier and more convenient for patients. Read More

FDA Recommends 2025-2026 COVID-19 Vaccines Be Monovalent, Target LP.8.1 Strain

by MM360 Staff | May 27, 2025 | Myeloma News

Source: Pharmacy Times articles Following a meeting of the Vaccines and Related Biological Products Advisory Committee, the FDA announced their recommendation of COVID-19 vaccines targeting LP.8.1, a strain of the JN.1 variant that has become dominant in the US. Read...

HER2 and HER3 ADCs in Focus: Clinical Pearls for Managing Emerging Toxicities

by MM360 Staff | May 27, 2025 | Myeloma News

Source: Pharmacy Times articles Corrine Stahura, PharmD, and Sophia Gilardone, PharmD, BCOP, discuss the distinct adverse effect profiles of HER2- and HER3-targeted antibody-drug conjugates—particularly the risk and management of interstitial lung disease—and offer...

Observation or treatment for smoldering multiple myeloma? A systematic review and meta-analysis of randomized controlled studies

by MM360 Staff | May 27, 2025 | Myeloma News

Source: Myeloma : nature.com subject feeds Post Content Read More

Correction: Revised free light chain reference intervals enhance risk stratification in monoclonal gammopathy of undetermined significance and reduce overdiagnosis

by MM360 Staff | May 27, 2025 | Myeloma News

Source: Myeloma : nature.com subject feeds Post Content Read More

FDA Approves Treprostinil Inhalation Powder for PAH and PH-ILD

by MM360 Staff | May 27, 2025 | Myeloma News

Source: Pharmacy Times articles The approval is based on findings from the INSPIRE trial, where treprostinil demonstrated efficacy in pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Read...
« Older Entries
Next Entries »

Recent Content

  • Glioma trial of intranasal therapy NEO100 fills all patient slots
  • WHO grants nonproprietary name to ovarian cancer cell therapy
  • Putative multiple myeloma susceptibility genes identified by exome sequencing of 347 familial and early-onset cases
  • Carvykti label updated to include survival benefit data in myeloma
  • Addition of daratumumab to standard triplet regimens achieved better survival in newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
  • Inflammatory markers from routine blood tests predict survival in multiple myeloma: a Systematic Review and meta-analysis
  • FDA approves ziftomenib to treat some relapsed leukemia patients
  • (no title)
  • The challenge of non-transplant eligible, newly diagnosed multiple myeloma
  • Camera pill to find pancreatic cancer seeks breakthrough status
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT